Gastric microcirculatory changes of Portal‐hypertensive rats can be attenuated by long‐term Estrogen‐progestagen treatment
Julián Panés, Maria Casadevall, Mercedes Fernández, Josep M. Piqué, Jaume Bosch, Roser Casamitjana, Isabel Cirera, Josep A. Bombí, Josep Terés, Juan Rodés – 1 November 1994 – It has been suggested that estrogen‐progestagen therapy may be useful in preventing bleeding from gastric angiodysplasia, a vascular lesion similar to that described in portal‐hypertensive gastropathy. In this study we assessed the effects of estrogen‐progestagen therapy on gastric microcirculation and systemic and splanchnic hemodynamics in portal‐hypertensive and sham‐operated rats.